IUS2:F:F-iShares S&P U.S. Banks UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 4.854

Change

+0.02 (+0.50)%

Market Cap

USD 0.33B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.08 (+0.30%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.89 (+1.76%)

USD 117.56B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.15 (+0.28%)

USD 97.02B
SXR8:F iShares Core S&P 500 UCITS ETF..

+0.62 (+0.11%)

USD 89.53B
EUNL:F iShares Core MSCI World UCITS ..

N/A

USD 72.04B
FRCJ:F UBS MSCI Japan Socially Respon..

+0.07 (+0.32%)

USD 71.25B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.05 (+0.30%)

USD 58.22B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 56.96B
VUAA:F Vanguard S&P 500 UCITS Acc

N/A

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

+0.22 (+0.23%)

USD 51.63B

ETFs Containing IUS2:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.51% 57% F 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.51% 55% F 56% F
Trailing 12 Months  
Capital Gain 31.08% 88% B+ 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 31.08% 86% B+ 74% C
Trailing 5 Years  
Capital Gain 20.37% 49% F 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 20.37% 49% F 44% F
Average Annual (5 Year Horizon)  
Capital Gain 8.61% 73% C 70% C-
Dividend Return 8.61% 72% C 63% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 37.91% 6% D- 29% F
Risk Adjusted Return 22.71% 47% F 53% F
Market Capitalization 0.33B 51% F 44% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.